CLCGY:OTC-Clicks Group Ltd (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 42.8

Change

+0.76 (+1.81)%

Market Cap

USD 5.14B

Volume

1.50K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Clicks Group Limited, together with its subsidiaries, operates as a health, wellness, and beauty retailer in South Africa and internationally. It operates through two segments: Retail and Distribution. The company retails pharmacy, health, and beauty through stores, and in-store pharmacies for the middle to upper income markets under the Clicks brand name. It also offers various range of mother and baby products including baby hardware, accessories, health, foods, diapers and wipes, and baby toiletries under the Clicks Baby brand; beauty therapy, grooming, and ethnic hair care under the Sorbet brand name; diabetic clinic, travel clinic, and wounds management practice under the M-KEM brand; and naturally-inspired beauty products under The Body Shop brand name. In addition, the company involved in the wholesale and supply of pharmaceutical products to retail pharmacies, private hospitals, dispensing doctors, and retail health stores under the UPD brand. The company was formerly known as New Clicks Holdings Limited and changed its name to Clicks Group Limited in June 2009. Clicks Group Limited was founded in 1968 and is headquartered in Cape Town, South Africa.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-05 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
JDHIY JD Health International Inc

N/A

USD 16.82B
ALBHF Alibaba Health Information Tec..

N/A

USD 10.86B
JDHIF JD Health International Inc

N/A

USD 10.33B
RADLY Raia Drogasil SA ADR

+0.53 (+21.29%)

USD 4.65B
SHPPF Shop Apotheke Europe N.V

N/A

USD 2.98B
SAEYY Shop Apotheke Europe N.V

-0.11 (-0.96%)

USD 2.96B
NOTR Nowtransit Inc

N/A

USD 0.57B
ZRSEF Zur Rose Group AG

N/A

USD 0.30B
BLMH Blum Holdings Inc

N/A

USD 0.01B
RLLVF Relevium Technologies Inc

N/A

USD 5.28M

ETFs Containing CLCGY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.27% 71% C- 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.27% 71% C- 56% F
Trailing 12 Months  
Capital Gain 31.98% 78% C+ 78% C+
Dividend Return 0.69% 50% F 7% C-
Total Return 32.67% 78% C+ 76% C+
Trailing 5 Years  
Capital Gain 57.41% 100% F 75% C
Dividend Return 10.93% 100% F 27% F
Total Return 68.34% 100% F 72% C
Average Annual (5 Year Horizon)  
Capital Gain 6.79% 60% D- 56% F
Dividend Return 8.78% 64% D 54% F
Total Return 1.99% 100% F 43% F
Risk Return Profile  
Volatility (Standard Deviation) 24.46% 88% B+ 79% B-
Risk Adjusted Return 35.88% 92% A 76% C+
Market Capitalization 5.14B 85% B 86% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector